Unlikely to cause harm — often a labeling or packaging issue.
Failed Impurities/Degradation Specifications: Out of Specification (OOS) for related substances test for Anhydro Simvastatin at the 06-month time point during long-term stability study.
| Brand name | EZETIMIBE AND SIMVASTATIN |
| Generic name | EZETIMIBE AND SIMVASTATIN |
| Active ingredient(s) | EZETIMIBE, SIMVASTATIN |
| Distributed by / for | Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430 |
| NDC | 68462-323-90 |
| Full product label | Ezetimibe and Simvastatin Tablets, 10mg/40mg, 90-count bottle, Rx only, Manufactured by: Glenmark Pharmaceuticals Ltd., Plot No. 2, Phase-2, Pharma Zone SEZ, Madya Pradesh, India, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, NDC 68462-323-90 |
| Recalling firm | Glenmark Pharmaceuticals Inc., USA |
| Distribution | Nationwide USA and PR |
| Quantity | 6,759 Con - 90 bottle pack |
| Recall initiated | 2025-05-19 |
| Report date | 2025-06-18 |
| Recall completed | — |
| Recall number | D-0462-2025 |
| Classification | Class III |
| FDA status | Ongoing |
| Origin on file | Mahwah NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗